Comparative study on the effect of aspirin, TP receptor antagonist and TxA


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
01 Dec 2021
Historique:
received: 02 09 2021
revised: 10 10 2021
accepted: 18 10 2021
pubmed: 25 10 2021
medline: 15 12 2021
entrez: 24 10 2021
Statut: ppublish

Résumé

Thromboxane (TxA Using isolated organ bath, saphenous vein and internal mammary artery preparations were incubated with TP receptor antagonist, TxS inhibitor, aspirin, IP or EP4 receptor antagonist. Then prostaglandin (PG)E TP receptor antagonist inhibited the contraction induced by PGE TP receptor antagonist and TxS inhibitor are more effective to reduce contraction induced by different spasmogens in comparison to aspirin. Our results suggest that TP receptor antagonist and TxS inhibitor might have an advantage over aspirin due to their preventive effect on increased vascular reactivity observed in post-operative period of coronary artery bypass grafting.

Identifiants

pubmed: 34688694
pii: S0024-3205(21)01060-2
doi: 10.1016/j.lfs.2021.120073
pii:
doi:

Substances chimiques

Benzofurans 0
Carbazoles 0
Enzyme Inhibitors 0
Receptors, Prostaglandin 0
Receptors, Thromboxane 0
Sulfonamides 0
Thromboxanes 0
Phenylephrine 1WS297W6MV
Arachidonic Acid 27YG812J1I
Thromboxane A2 57576-52-0
Thromboxane-A Synthase EC 5.3.99.5
furegrelate KX4D9BZA6X
ramatroban P1ALI72U6C
Aspirin R16CO5Y76E

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120073

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Gulsev Ozen (G)

Department of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey. Electronic address: gulsevozen@istanbul.edu.tr.

Khadija Aljesri (K)

Department of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.

Heba Abdelazeem (H)

Université de Paris, INSERM, UMR-S 1148, CHU X. Bichat, 75018 Paris, France; Université Sorbonne Paris Nord, 93430 Villetaneuse, France; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt.

Xavier Norel (X)

Université de Paris, INSERM, UMR-S 1148, CHU X. Bichat, 75018 Paris, France; Université Sorbonne Paris Nord, 93430 Villetaneuse, France.

Gulsum Turkyılmaz (G)

Department of Cardiovascular Surgery, Bakirkoy Dr Sadi Konuk Education and Research Hospital Bakırkoy, Istanbul, Turkey.

Saygın Turkyılmaz (S)

Department of Cardiovascular Surgery, Bakirkoy Dr Sadi Konuk Education and Research Hospital Bakırkoy, Istanbul, Turkey.

Gokce Topal (G)

Department of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH